# OnCo record immunome (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/immunome/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "immunome" ;
  schema:name "Immunome"@en ;
  schema:alternateName "Immunome, Inc."@en, "Ayala Pharmaceuticals"@en ;
  schema:description "Immunome is a US biotechnology company whose lead drug varegacestat, a gamma-secretase inhibitor acquired with Ayala Pharmaceuticals, completed the phase 3 RINGSIDE trial in progressing desmoid tumours; it also develops antibody-drug conjugates."@en ;
  schema:url <https://onco.cc/companies/immunome/>, <https://immunome.com/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://immunome.com/>, <https://clinicaltrials.gov/search?lead=Immunome> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/desmoid-tumour/> ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/> ;
  onco:targets <https://onco.cc/targets/gamma-secretase/> ;
  onco:drugs <https://onco.cc/drugs/varegacestat/> ;
  onco:trials <https://onco.cc/trials/nct04871282/> .
